Cholangiocarcinoma
摘要
The role of fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography in cholangiocarcinoma depends on its morphologic characteristics and location. It is useful in detecting regional and distal metastases. This chapter will answer common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in cholangiocarcinoma.